entity

Biomarker

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Biomarker: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

16Connections
22Hypotheses
0Analyses
11Outgoing
5Incoming
7Experiments
0Debates

No AI portrait yet

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Experiment Prioritization Index — Neurodegeneration

general · 3915 words

Cerebrospinal Fluid (CSF) Biomarkers Overview

biomarker · 4101 words

Beta-Amyloid 42/40 Ratio - Biomarker

biomarker · 3667 words

MDS 2026 — Fluid Biomarker Advances in Neurodegeneration

event · 3615 words

MDS 2026 — Fluid Biomarker Advances in Neurodegeneration

event · 3615 words

Tumor Necrosis Factor Alpha (TNF-α) as a Neurodegenerative Disease Biomarker

biomarker · 3602 words

Outgoing (11)

TargetRelationTypeStr
h-var-3049fa9ae4targeted_byhypothesis1.00
h-cef0dd34targeted_byhypothesis1.00
Agingbiomarker_forprocess0.95
Prostate Cancerbiomarker_fordisease0.95
Thyroid Cancerbiomarker_fordisease0.95

Incoming (5)

SourceRelationTypeStr
h-cef0dd34targetshypothesis1.00
h-var-3049fa9ae4targetshypothesis1.00
HMGB1biomarker_forprotein0.80
Disease-Associated Microgliabiomarker_forcell_type0.75
NEUROPROTEOMICSidentifiespathway0.64

Targeting Hypotheses (22)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Multi-Biomarker Composite Index Surpassing Amyloid PET for T 0.933 neurodegeneration What amyloid threshold level is required
Ketone Utilization Index as Metabolic Flexibility Biomarker 0.819 translational neuroscience Which metabolic biomarkers can distingui
CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Wind 0.801 neuroimmunology What is the temporal sequence of TREM2 s
Integrated Biomarker Panel for Therapeutic Window Identifica 0.784 neurodegeneration What are the precise temporal dynamics o
sTREM2 as Biomarker of Cystatin-C Therapeutic Efficacy 0.757 neurodegeneration View
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in 0.735 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
p16^INK4a-CCF Axis as Senolytic Timing Biomarker 0.725 molecular biology What is the optimal therapeutic window t
Creatine Kinase System Capacity as Neural Energy Reserve Bio 0.707 translational neuroscience Which metabolic biomarkers can distingui
Pericyte-targeted senolysis or senomorphic therapy will bene 0.700 neurodegeneration Does pericyte senescence drive BBB break
Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification 0.677 translational neuroscience Which metabolic biomarkers can distingui
Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio 0.665 translational neuroscience Which metabolic biomarkers can distingui
Mitochondrial Biogenesis Rate as a Dynamic Biomarker of Neur 0.652 translational neuroscience Which metabolic biomarkers can distingui
TREM2-Driven Senescence Biomarker Index for Predicting Neuro 0.642 neurodegeneration Gene expression changes in aging mouse b
CSF Biomarker-Guided ABCA7 Therapeutic Dosing 0.619 neurodegeneration Why does the V1613M variant reduce amylo
Autophagy-Epigenetic Feedback Loop Creates a Compounding Bio 0.583 - Epigenetic clocks as biomarkers for Alzh
Dynamic Microglial Phenotype Switching Biomarker Panel for N 0.577 neurodegeneration What amyloid threshold level is required
Real-time closed-loop transcranial focused ultrasound target 0.542 Alzheimer's disease Circuit-level neural dynamics in neurode
Basal cGAS Derepression as Stratification Biomarker 0.520 neurodegeneration What determines the specificity of TDP-4
High baseline tau and ISR activation may lower the effective 0.510 neurodegeneration -
TDP-43 Pathology Creates a Distinct Epigenetic Clock "Signat 0.483 - Epigenetic clocks as biomarkers for Alzh
Gamma-Entrained P-tau217 Biomarker Cascades Optimize lncRNA- 0.431 molecular neurobiology View
GrimAge Acceleration as a Cell-Type-Resolved CSF Biomarker P 0.351 - Epigenetic clocks as biomarkers for Alzh

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (7)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
AECII-specific HMGCS2 overexpression in mouse pulmonary fibrosis validation idiopathic pulmonary fibrosis 0.950 0.00 C57BL/6 mice with AECII-specif proposed N/A
Ketogenic diet fat threshold analysis in wild-type mice validation metabolic disease 0.900 0.00 C57BL/6J wild-type mice proposed N/A
HMGCS2 gain-of-function in AECII lipid metabolism regulation exploratory idiopathic pulmonary fibrosis 0.900 0.00 human AECIIs proposed N/A
Ketogenic diet efficacy in diet-induced obese mice validation obesity, metabolic disease 0.900 0.00 C57BL/6J diet-induced obese mi proposed N/A
Chi3l1 deletion effects on baseline glial activation in mice validation baseline neuroinflammation 0.900 0.00 Chi3l1 knockout mice proposed N/A
Microarray and single-cell RNA analysis of lipid metabolism genes exploratory idiopathic pulmonary fibrosis 0.850 0.00 human patients, mouse models proposed N/A
CHI3L1 variant association with AD progression in human patients exploratory Alzheimer's disease 0.850 0.00 human patients proposed N/A

Related Papers (9)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis [PMID:40771159] Padilla CM, Lafyatis R, Gibson KF, Morse Arthritis Care Res (Hoboken) 2026 0
Obstructive sleep apnea, biomarker profiles, and clinical progression in Parkins [PMID:41499940] Zhu S, An D, Liu X Sleep Med 2026 0
SuPAR levels are increased in sera of euthymic patients with bipolar disorder an [PMID:41605346] Kök Kendirlioğlu B, Çörekli Kaymakçı E, J Affect Disord 2026 0
Chitinase-like Proteins YKL-40 and YKL-39 in Colorectal Cancer. [PMID:41677627] Ivanova T, Kazakova M, Dikov D, Dzhambov Cells 2026 0
Correction: CHI3L1: An Emerging Player in Neuroinflammation and Neurodegeneratio [PMID:41699333] Mushtaq Umar; Seh Bilal Ahmad; Khanday F Molecular Neurobiology 2026 0
UNC93B1 promotes pancreatic cancer progression through modulation of cGAS-STING [PMID:41716413] Yang H, Li Y, Su J, Zhang H, Zhu W et al Front Immunol 2026 0
Association of Alzheimer's disease progression with YKL40 levels in peripheral b [PMID:41725729] Yang Q, Wang R, Pei J, Fu Q, Zhan Y et a Front Neurol 2026 0
Constitutive neuronal expression and disease-associated upregulation of chitinas [PMID:41762671] Gaur N, Angerer C, Gunes ZI, Ancau M, Wa Brain 2026 0
Plasma CHI3L1 as a marker of cognitive and structural brain changes in radiologi [PMID:41953284] Schneider R, Brand-Arzamendi K, Lim TR, BMJ Neurol Open 2026 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Biomarker in their description or question text

Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Anta

Score: 0.735 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Antagonist in Tau Ph

p16^INK4a-CCF Axis as Senolytic Timing Biomarker

Score: 0.725 · molecular biology · 2026-04-21

**Molecular Mechanism and Rationale** The p16^INK4a-CCF axis represents a sophisticated temporal biomarker system that

Creatine Kinase System Capacity as Neural Energy Reserve Biomarker

Score: 0.707 · translational neuroscience · 2026-04-16

## Mechanistic Overview Creatine Kinase System Capacity as Neural Energy Reserve Biomarker starts from the claim that mo

Pericyte-targeted senolysis or senomorphic therapy will benefit only an early bi

Score: 0.700 · neurodegeneration · 2026-04-25

Therapeutic benefit from pericyte-directed senescence interventions depends on stage. If BBB leak and dysfunction occur

Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification Biomarker

Score: 0.677 · translational neuroscience · 2026-04-16

## Mechanistic Overview Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification Biomarker starts from the claim tha

Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interfa

Score: 0.665 · translational neuroscience · 2026-04-12

## Mechanistic Overview Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interface Biomarker sta

Mitochondrial Biogenesis Rate as a Dynamic Biomarker of Neuroprotection

Score: 0.652 · translational neuroscience · 2026-04-12

## Mechanistic Overview Mitochondrial Biogenesis Rate as a Dynamic Biomarker of Neuroprotection starts from the claim th

TREM2-Driven Senescence Biomarker Index for Predicting Neurodegeneration Risk

Score: 0.642 · neurodegeneration · 2026-04-20

**Molecular Mechanism and Rationale** The TREM2 (Triggering Receptor Expressed on Myeloid cells 2) pathway represents a

CSF Biomarker-Guided ABCA7 Therapeutic Dosing

Score: 0.619 · neurodegeneration · 2026-04-14

## **Molecular Mechanism and Rationale** ABCA7 (ATP-binding cassette transporter A7) functions as a critical lipid effl

Autophagy-Epigenetic Feedback Loop Creates a Compounding Biomarker Signal — Auto

Score: 0.583 · unknown disease · 2026-04-25

Concise Statement: Progressive failure of autophagy flux in AD neurons produces a cascading epigenetic feedback loop —

Dynamic Microglial Phenotype Switching Biomarker Panel for Neuroinflammatory Tre

Score: 0.577 · neurodegeneration · 2026-04-20

**Molecular Mechanism and Rationale** The molecular foundation of this biomarker panel centers on the intricate interpl

Real-time closed-loop transcranial focused ultrasound targeting PV interneurons

Score: 0.542 · Alzheimer's disease · 2026-04-21

## Mechanistic Overview Real-time closed-loop transcranial focused ultrasound targeting PV interneurons with API-integra

Basal cGAS Derepression as Stratification Biomarker

Score: 0.520 · neurodegeneration · 2026-04-21

## Mechanistic Overview Basal cGAS Derepression as Stratification Biomarker starts from the claim that modulating cGAS p

TDP-43 Pathology Creates a Distinct Epigenetic Clock "Signature Divergence" Dete

Score: 0.483 · unknown disease · 2026-04-25

Concise Statement: TDP-43 proteinopathy (as seen in LATE — Limbic-predominant Age-related TDP-43 Encephalopathy) genera